From: Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms
Time to treatment (h) | TXA allocated | Placebo allocated | Risk ratio (95% CI) |
---|---|---|---|
≤1 | 198/3747 (5 · 3%) | 286/3704 (7 · 7%) | 0 · 68 (0 · 57–0 · 82) |
>1 to ≤3 | 147/3037 (4 · 8%) | 184/2996 (6 · 1%) | 0 · 79 (0 · 64–0 · 97) |
>3 | 144/3272 (4 · 4%) | 103/3362 (3 · 1%) | 1 · 44 (1 · 12–1 · 84) |